Honeywell International Stock HON · Forecast & Analysis
Honeywell International's overall picture is bullish, led by the Aerospace segment's raised full-year earnings and free cash flow guidance. The verdict rests on fundamentals alone, with a securities class action facing HON as the main counterweight.
News situation · 3 items / 30 D
3 of 3 straight from the issuer or regulator
Outlook for Honeywell International Inc.
Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.
No price statement: there is no price data for this asset. Based on 3 news items.
What drives it
- Aerospace raised its full-year adjusted EPS guidance after Q3 sales of $4.6 billion grew 2% organically.
- Second-half free cash flow projections were increased alongside the earnings outlook.
- A third-party study names the company a key player in fast-growing smart manufacturing through 2032.
What argues against it
- A securities class action alleges the CEO and CFO misled investors about supplier constraints.
- Standalone costs held Aerospace adjusted EBIT growth to just 1%, well below sales growth.
- Heavy US data in the days ahead, including producer prices and retail sales, sets a shifting macro backdrop.
What would change the picture
- Resolution or narrowing of the securities class action would remove the largest legal overhang.
- Signs that standalone costs are easing would let profit growth catch up with sales.
- Guidance reaffirmed or raised at the next update would reinforce the fundamental case.
Coming up
- US: Retail sales · expected 0.7%, previous 0.9%
- US: EIA Crude Oil Stocks Change · expected -0.309M, previous 4.657M
- US: Jobless claims, Philadelphia Fed Manufacturing Index · expected 32.2, previous 20.9
Economic data for HON
Full calendarRecently released
- November 13, 2026USDCore PPI m/m●●●Actual 0.3%Forecast 0.4%Previous 0.8%
- November 13, 2026USDPPI m/m●●●Actual 0.3%Forecast 0.4%Previous 1.4%
Coming up
- TomorrowUSDCore Retail Sales m/m●●●Forecast 0.7%Previous 0.9%in 1 day
- TomorrowUSDRetail Sales m/m●●●Forecast 0.3%Previous 0.8%in 1 day
- November 18, 2026USDEIA Crude Oil Stocks Change●●●Forecast -0.309MPrevious 4.657Min 2 days
- November 19, 2026USDInitial Jobless Claims●●●in 3 days
- November 19, 2026USDPhiladelphia Fed Manufacturing Index●●●Forecast 32.2Previous 20.9in 3 days
- November 20, 2026USDMichigan Consumer Sentiment●●●Forecast 51.0Previous 51.0in 4 days
All times UTC. Assessed against the consensus forecast, otherwise against the previous value.
Both worlds over time
Technical and news signals of the last 90 days on one timeline.
What is being reported about HON
Frequently asked questions about Honeywell International Inc.
What is driving the bullish view on Honeywell right now?
The Aerospace segment reported Q3 sales of $4.6 billion, up 2% in both reported and organic terms, and management raised full-year adjusted EPS guidance and second-half free cash flow projections. Those upward revisions outweigh the cost pressures noted in the same report.
How serious is the lawsuit against HON's leadership?
The class action names the CEO and CFO and alleges public disclosures understated the impact of concentrated supplier constraints. Potential exposure includes legal costs, possible settlements and reputational damage. It is early-stage litigation, so the eventual outcome and any financial impact remain uncertain.
Why is there no chart or price reading for this asset?
The price history for HON is still too short to support a technical statement or an outlook window, so this assessment is built entirely on company news. The bullish lean reflects the raised guidance, while the litigation is the clearest argument on the other side.
📝 Overview Generated automatically
HON has been the subject of 18 signals across 18 articles in the last 365 days. Sentiment skews Neutral (39%).
Breakdown: 6 bullish, 5 bearish, 7 neutral.
Most-cited catalysts: Quantinuum's IPO filing unlocks value for Honeywell's quantum investment (1×), Positive market reception could lift Honeywell shares (1×), Quantinuum’s upsized IPO target may boost the mark-to-market valuation of Honeywell’s stake. (1×). Most-cited risk factors: Adverse IPO market conditions could delay or reduce the offering (1×), Quantinuum's high cash burn may concern investors (1×), Quantinuum may fail to sell shares at the higher target if investor demand softens. (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.